Clinical Trial

The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

Study acronym: ARTISSE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.
Protocol Amendment History 1 change
notable Trial sites expanded: 19 -> 22 locations 2026-05-06
Trial Details
NCT Number NCT02998229
Lead Sponsor Medtronic Neurovascular Clinical Affairs
Conditions Intracranial Aneurysm
Enrollment 300 participants
Start Date 2024-04-16
Primary Completion 2027-08 (estimated)
Study Completion 2032-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-14